Acadia Pharmaceuticals Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $69.4M | $163.6M | $102.1M | $61.9M | $11.7M | $57.9M | $6.9M | $6.8M |
| Accounts Receivable | $17.3M | $5.9M | — | — | — | — | — | — |
| Inventory | $5.2M | $4.2M | — | — | — | — | — | — |
| Total Current Assets | $373.5M | $547.9M | $219.0M | $324.6M | $188.4M | $108.5M | $31.9M | $37.8M |
| Property, Plant & Equipment | $2.7M | $3.1M | $2.2M | $553.0K | $579.0K | $42.0K | $151.0K | $426.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $5.5M | $7.0M | — | — | — | — | — | — |
| Total Assets | $384.5M | $561.2M | $221.9M | $325.5M | $189.1M | $108.6M | $32.1M | $38.4M |
| Liabilities | ||||||||
| Accounts Payable | $8.8M | $3.9M | $1.7M | $2.0M | $372.0K | $1.4M | $2.0M | $2.0M |
| Total Current Liabilities | $49.0M | $42.6M | $21.9M | $15.8M | $7.0M | $5.9M | $6.2M | $6.0M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $49.2M | $42.7M | $22.1M | $16.0M | $7.0M | $5.9M | $8.8M | $8.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.22B | $-934.0M | $-662.6M | $-498.1M | $-405.7M | $-367.7M | $-346.9M | $-324.1M |
| Total Stockholders' Equity | $335.3M | $518.4M | $199.8M | $309.5M | $182.1M | $85.0M | $23.4M | $29.7M |